Your browser doesn't support javascript.
COVID-19 vaccination: Evaluation of risk for protection failure in chronic lymphocytic leukemia patients.
Del Poeta, Giovanni; Bomben, Riccardo; Polesel, Jerry; Rossi, Francesca Maria; Pozzo, Federico; Zaina, Eva; Cattarossi, Ilaria; Varaschin, Paola; Nanni, Paola; Boschian Boschin, Romina; Postorino, Massimiliano; Laureana, Roberta; Pasqualone, Gianmario; Steffan, Agostino; Gentile, Massimo; Zucchetto, Antonella; Gattei, Valter.
  • Del Poeta G; Division of Hematology, University of Tor Vergata, Rome, Italy.
  • Bomben R; Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Italy.
  • Polesel J; Unit of Cancer Epidemiology, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy.
  • Rossi FM; Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Italy.
  • Pozzo F; Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Italy.
  • Zaina E; Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Italy.
  • Cattarossi I; Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Italy.
  • Varaschin P; Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Italy.
  • Nanni P; Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Italy.
  • Boschian Boschin R; Immunopathology and Cancer Biomarkers, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Italy.
  • Postorino M; Division of Hematology, University of Tor Vergata, Rome, Italy.
  • Laureana R; Division of Hematology, University of Tor Vergata, Rome, Italy.
  • Pasqualone G; Division of Hematology, University of Tor Vergata, Rome, Italy.
  • Steffan A; Immunopathology and Cancer Biomarkers, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Italy.
  • Gentile M; Hematology Unit, Azienda Ospedaliera of Cosenza, Cosenza, Italy.
  • Zucchetto A; Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Italy.
  • Gattei V; Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Italy.
Hematol Oncol ; 39(5): 712-714, 2021 Dec.
Article in English | MEDLINE | ID: covidwho-1378932
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Leukemia, Lymphocytic, Chronic, B-Cell / Vaccination / COVID-19 Vaccines / SARS-CoV-2 / COVID-19 / Antibodies, Viral / Antibody Formation Type of study: Cohort study / Experimental Studies / Prognostic study Topics: Vaccines Limits: Aged / Female / Humans / Male Language: English Journal: Hematol Oncol Year: 2021 Document Type: Article Affiliation country: Hon.2916

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Leukemia, Lymphocytic, Chronic, B-Cell / Vaccination / COVID-19 Vaccines / SARS-CoV-2 / COVID-19 / Antibodies, Viral / Antibody Formation Type of study: Cohort study / Experimental Studies / Prognostic study Topics: Vaccines Limits: Aged / Female / Humans / Male Language: English Journal: Hematol Oncol Year: 2021 Document Type: Article Affiliation country: Hon.2916